Validation of a treatment selection algorithm for optimal choice of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups
Güdemann LM., Young KG., Cardoso P., Mateen BA., Holman RR., Sattar N., Pearson ER., Hattersley AT., Jones AG., Shields BM., Dennis JM.